Landmark Summit Puts Women at Heart of Global Health Agenda

Global leaders unite to provide 120 million women in the world’s poorest countries with access to contraceptives by 2020. Voluntary family planning services will reach an additional 120 million women and girls in the world’s poorest countries by 2020 thanks to a new set of commitments announced today by more than 150 leaders from donor and developing countries, international agencies, civil society, foundations and the private sector.

Merck Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning

Merck, known as MSD outside the United States and Canada, and the Bill & Melinda Gates Foundation today announced that they will work together to expand access to family planning, a critical step in improving the health of women around the world. Merck intends to pledge up to $25 million over eight years as part of Merck for Mothers – the company’s 10-year initiative to reduce maternal mortality around the world. This pledge will be matched by the Gates Foundation as part of its commitment to family planning. These contributions will advance efforts to help reach United Nations Millennium Development Goal 5, which calls for a 75 percent reduction in maternal mortality and universal access to reproductive health by 2015.

Zambia: USAID, Merck to Inject U.S$8 Million in Health Service Delivery

THE United States Agency for International Development (USAID) and Merck, a global health care company, will each invest US$4 million in the newly launched Zambia Management and Leadership Academy (ZMLA). ZLMA will equip health care managers with knowledge and skills to enhance health care delivery in Zambia. Currently, over 360 health care managers are being trained and a further 900 others will be trained by 2014.

7 pharmaceutical companies join academic researchers to speed TB drug discovery

Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, have launched a groundbreaking partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB). The partnership, known as the TB Drug Accelerator (TBDA), will target the discovery of new TB drugs by collaborating on early-stage research. The long-term goal of the TBDA is to create a TB drug regimen that cures patients in only one month.

The National Association of People with AIDS and OraSure Technologies launch eighth Mayor's Campaign against HIV for National HIV Testing Day on June 27

The National Association of People with AIDS (NAPWA) and OraSure Technologies, Inc. announced today the launch of the eighth annual Mayors Campaign Against HIV™, a national campaign to encourage testing for HIV and promote the benefits of knowing one’s HIV status. The Campaign is part of the annual observance of National HIV Testing Day (NHTD) on Wednesday, June 27, 2012.

Alvos Biotecnologia, a company created by Biominas Brasil, had an effective participation in the development of a Brazilian vaccine against schistosomiasis

Brazil has created and will produce a vaccine against Schistosomiasis, a chronic illness caused by the Schistosoma parasite found in areas that lack basic sanitation. On June, 12 in Rio de Janeiro, Fundação Oswaldo Cruz (Fiocruz) issued the results of clinical safety testing for the vaccine developed by the Experimental Schistosomiasis Laboratory of Instituto Oswaldo Cruz (IOC/Fiocruz). Based on the antigen Sm14, developed and patented by the IOC, the vaccine puts Brazil at the forefront of knowledge in a field of high technological complexity.

Emergence Of Drug Resistance To ARVs Has Potential To 'Curb, And Even Reverse' Gains Against HIV

Noting that the "[r]oll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.

Case Studies Focus on Role of Multi-Sector Collaborations to Address Global Health Challenges

Online Collection Illustrates Efforts of Productive Partnerships

May 18, 2012 – Chicago, IL – Successful multi-sector global health programs engage partners and policymakers early, communicate openly and frequently with relevant stakeholders, and empower and involve communities, according to a website relaunched this week, Case Studies for Global Health,

More than a third of anti-malarial drugs in SE Asia fake, finds study

Radio Australia
May 24, 2012

A new American study has found that fake malaria drugs are threatening the gains made in the fight against the deadly disease.

Researchers at the US National Institute of Health have found that more than one third of the anti-malarial drugs in Southeast Asia are fake and that a third of samples in sub-Saharan Africa don't contain the right ingredients.

Dr Margaret Chan appointed to a second term as Director-General

The World Health Assembly today appointed Dr Margaret Chan for a second five-year term as Director-General of the World Health Organization (WHO). In her acceptance speech to health ministers and representatives of WHO’s Member States, Dr Chan pledged her continued commitment to improve the health of the most vulnerable. In addition she said that the biggest challenge over the next five years will be to lead WHO in ways that will help maintain the unprecedented momentum for better health that marked the start of this century.